- Home
- ISSC vs AVTX Comparison
ISSC vs AVTX Comparison
Compare ISSC & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISSC
- AVTX
- Stock Information
- Founded
- ISSC 1988
- AVTX 2011
- Country
- ISSC United States
- AVTX United States
- Employees
- ISSC N/A
- AVTX N/A
- Industry
- ISSC EDP Services
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ISSC Technology
- AVTX Health Care
- Exchange
- ISSC Nasdaq
- AVTX Nasdaq
- Market Cap
- ISSC 273.0M
- AVTX 248.3M
- IPO Year
- ISSC 2000
- AVTX 2015
- Fundamental
- Price
- ISSC $10.39
- AVTX $17.86
- Analyst Decision
- ISSC
- AVTX Strong Buy
- Analyst Count
- ISSC 0
- AVTX 9
- Target Price
- ISSC N/A
- AVTX $30.14
- AVG Volume (30 Days)
- ISSC 319.6K
- AVTX 533.4K
- Earning Date
- ISSC 08-14-2025
- AVTX 11-07-2025
- Dividend Yield
- ISSC N/A
- AVTX N/A
- EPS Growth
- ISSC 78.33
- AVTX N/A
- EPS
- ISSC 0.66
- AVTX N/A
- Revenue
- ISSC $77,434,581.00
- AVTX $441,000.00
- Revenue This Year
- ISSC $71.55
- AVTX N/A
- Revenue Next Year
- ISSC $15.19
- AVTX N/A
- P/E Ratio
- ISSC $15.78
- AVTX N/A
- Revenue Growth
- ISSC 72.82
- AVTX N/A
- 52 Week Low
- ISSC $5.30
- AVTX $3.39
- 52 Week High
- ISSC $20.00
- AVTX $19.41
- Technical
- Relative Strength Index (RSI)
- ISSC 36.62
- AVTX 69.10
- Support Level
- ISSC $10.37
- AVTX $15.58
- Resistance Level
- ISSC $11.64
- AVTX $19.40
- Average True Range (ATR)
- ISSC 0.64
- AVTX 1.60
- MACD
- ISSC -0.10
- AVTX 0.25
- Stochastic Oscillator
- ISSC 15.92
- AVTX 72.86
About ISSC Innovative Solutions and Support Inc.
Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).